Dublin, March 24, 2017 -- Research and Markets has announced the addition of the "Global Vitreoretinal Surgery Devices Market (By Product, By End User, By Region, By Country): Opportunities and Forecast (2016-2021)" report to their offering.
Global Vitreoretinal Surgery Device Market is forecasted to grow at a CAGR of 5.20% during 2016-2021
The strong growth in Vitreoretinal Surgery Device market is driven by increase in aging population, increased penetration in emerging economies and technological development in vitreoretinal surgery.
Vitrectomy Machines & Packs hold the major percentage share in the total market and is also the fastest growing segment. Among the regions, North America holds the largest market share mainly due to well established healthcare system and introduction of advanced next generation vitrectomy machines and minimally invasive surgery. However, APAC is expected to grow at a faster pace during forecasted period.
Scope of the Report
The report provides coverage by Type, Mode of Application and End User:
By Product
- Vitrectomy Machines & Packs
- Photocoagulation Surgery Devices
- Illumination Devices
- Others
By End User
- Hospitals
- Free Standing Ambulatory Surgery Center
Company Profiles
- Alcon
- Bausch & Lomb
- Carl Zeiss Meditec AG
- NIDEK CO., LTD.
- Topcon Corporation
- OCULUS
- MedOne Surgical, Inc.
- D.O.R.C
- Optikon
- Peregrine Surgical
For more information about this report visit http://www.researchandmarkets.com/research/s7wtnz/global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Surgical Devices


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Instagram Outage Disrupts Thousands of U.S. Users
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



